Literature DB >> 17592572

Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension.

Dorde Culafić1, Mirjana Perisić, Ivan Boricić, Violeta Culafić-Vojinović, Miodrag Vukcević.   

Abstract

Amyloidosis is not a single disease, but a series of diseases in which there is extracellular deposition of a protein in an abnormal fibrillar form. We report a 48-year old woman with subicteric coloration of scleras and hepatomegaly. Functional liver tests evidenced a high level of alkaline phosphatase and serum gamma-glutamyl transpeptidase with mild increase of bilirubin level. Color Doppler ultra-sonography, showed a hyperkinetic portal hypertension. The liver biopsy found amyloid in sinusoids subendothelially. Immunohistochemical staining for anti lambda light chain immunoglobulin was positive. Bone marrow morphology and immunohistochemistry confirmed lymphoplasmocytic lymphoma with amyloidosis.

Entities:  

Mesh:

Year:  2007        PMID: 17592572

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  4 in total

1.  Primary amyloidosis presenting as cholestatic jaundice.

Authors:  Lukasz T Polanski; Sheraz R Markar; Thomas Satyadas; Raj Praseedom; Ashley Shaw
Journal:  BMJ Case Rep       Date:  2010-05-19

2.  Primary Amyloidosis Manifesting as Cholestatic Jaundice after Laparoscopic Cholecystectomy.

Authors:  Evangelos P Misiakos; George Bagias; Dina Tiniakos; Konstantinos Roditis; Nick Zavras; Ioannis Papanikolaou; Panagiotis Tsirigotis; Theodore Liakakos; Anastasios Machairas
Journal:  Case Rep Surg       Date:  2015-06-07

3.  Extensive loculated ascites in hepatic amyloidosis.

Authors:  Saranya Buppajarntham; Pongsathorn Kue-A-Pai
Journal:  N Am J Med Sci       Date:  2014-07

4.  A preliminary study of the effect of a high-salt diet on transcriptome dynamics in rat hypothalamic forebrain and brainstem cardiovascular control centers.

Authors:  Chitra Devi Ramachandran; See Ziau Hoe; Khadijeh Gholami; Sau Kuen Lam
Journal:  PeerJ       Date:  2020-03-03       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.